Pharmacies Model Development and earnings.docVIP

 PAGE \* MERGEFORMAT 5 Pharmacies Model Development and earnings At present, China’s pharmacy management, operation situation how? Respectively, showing what characteristics? What will appear new trends? With the policy and operating environment changes, what changes will occur profit model? From the 1990s, China began to implement OTC drugs pharmaceutical industry classification marks, since 2000 China since the implementation of the drug classification system, China’s retail pharmacies after nearly two decades of development, along with the rapid development of China’s reform and development in China, many population and the rapid growth of the national economy context, pharmaceutical retail industry with the development of the industry ushered in unprecedented opportunities and initially made gratifying achievements and great progress. The rapid development of China’s pharmaceutical retail industry and gradually improve the supervision and management of drugs legalization and standardization pace. Gradually formed a central city dominated by pharmaceutical retail chain, County market monomer pharmacies and primary health care institutions as the main retail system of medicines. Formed a sales over one billion yuan more than the national cross-regional drug retail chain pharmacies, pharmaceutical retail market the central city area has gradually been several major retail chain pharmacy division dominance gradually form a pattern. From Nepstar pharmaceutical chain in the United States listed on the NYSE to the nearest Yunnan Hongxiang medicine, Yixintang pharmaceutical chain in the domestic A-share market, pharmaceutical retail chain enterprises listed on the pace began to move. Pharmaceutical retail industry concentration, scale gradually accelerated. National pharmaceutical retail hundred, two hundred companies in retail market share is gradually increasing All of these developments indicate that the development of China’s pharmaceutical retail